Experience Using Euphorbia Hirta Tea*
as a Dietary Supplement While Experiencing Chemotherapy-Induced
By: MLC 12Dec2013
December 12, 2013: I
am a 78-year-old female living in Jacksonville, Florida who was diagnosed with
a very large abdominal tumor in January 2013.
My oncologist in South Florida treated my condition as a case of cholangiocarcinoma. I was placed on carboplatin-gemcitabine combination
chemotherapy regimen given in 28-day cycles.
During the course of my treatment some of my weekly scheduled sessions were
considerably delayed to as much as three weeks because of chemotherapy-induced
thrombocytopenia; my blood platelet counts were as low as less than 20 x 10/uL.
The low platelet counts in those instances were usually observed to
occur between the 14th day and the 28th day of a given cycle; each of those episodes generally required platelet
transfusions. After seriously considering
the suggestions of several family members and close friends—many of whom are in
the medical field with direct personal experiences with Euphorbia hirta
as used in dengue hemorrhagic fever to promote the production of blood
platelets and who are also aware of Euphorbia
hirta’s antioxidant effects and hepatoprotective effects—I took Euphorbia hirta tea* as a dietary
supplement. I first took Euphorbia hirta tea when my blood platelet
count was about 40 x 10/uL
(it was about 80 x 10/uL
a week earlier which prompted my oncologist to place my scheduled dose on hold).
A week after taking the Euphorbia hirta
tea,* my blood platelet count went up to more than 180 x 10/uL, enabling me to resume weekly
scheduled therapy. Since that time, I
have been taking Euphorbia
tea daily for five days each prior to my weekly scheduled chemotherapy as
follows. I am still taking** 1 cup daily
at bedtime, increasing it to 1 cup twice a day (after breakfast and at bedtime)
if my blood platelet count is less than 150 x 10/uL.
Except for its mild bitterly pungent aftertaste, I have not experienced
any untoward effects from taking the Euphorbia
hirta tea. Side effects from my
chemotherapy regimen, such as loss of appetite, nausea and fatigue, have been
very minimal. Just a note, I
concurrently take a beta-blocker for
hypertension and statin for hypercholesteremia—both of these medicines were
prescribed by my primary care physician.
I also take daily doses of over-the-counter Vitamin B complex and
Vitamin C tablets. At the time of this
writing, I am at the end my 9th cycle; my most recent CEA level is 8.9
ng/mL—down from the baseline value of 69.9 ng/mL; and, my latest CT scan showed
that the tumor has shrunk to more than 50% when compared to its baseline size.
October 3, 2014: Today, I finished my 5 day-a-week radiation
therapy for 6 weeks along with a weekly 5-FU.
It was started on August 25 after my CEA steadily increased to 28.3 in
the last 6 months. My CT and PET scans,
however, showed "no significant interval change[s]" during the same time period. My therapy regimen of external radiation and 5-FU has never been delayed because my
platelet counts have never gone down below 100 x 10/uL during the treatment course.
is the procedure that I personally follow when preparing 5 cups of Euphorbia hirta tea: Boil 5¼ cups of clean drinking water in a covered
pot. Once the water is visibly boiling, turn
the heat off. Add around 15 grams of
air-dried chopped Euphorbia hirta
plant (leaves, stems, roots and seeds) harvested from the wild or organically
grown (Euphorbia hirta for Tea Infusion at Amazon). With the pot covered, leave the concoction to
cool down for at least 3-4 hours. Pour
the concoction through a very fine mesh sieve into an appropriate container to substantially
strain out all of the bits of the chopped Euphorbia
hirta plant. Refrigerate tea. Consume tea at room temperature. Do not reheat.
example, if I received my chemotherapy dose on a Tuesday and I am scheduled to
receive my next dose on the following Tuesday, I would take Euphorbia hirta tea on Thursday, Friday,
Saturday, Sunday and Monday.
have not been evaluated by the Food and Drug Administration. Euphorbia
hirta tea as presented here is not intended to diagnose, treat, cure, or
prevent any disease condition.
the provided information on this page and for that matter, all information
presented in this website, is only for educational purposes. It is not intended (nor should it be used and
or construed as such) to diagnose, prescribe, prevent, treat or cure any
disease or condition. Use of information
on this website is not a replacement for proper medical consultation and or
care. Any questions regarding your own
health should be addressed to your physician or other health care
provider. By using this website you
agree that neither DREWMARC CLINICAL RESEARCH nor any party connected with the
same will be liable or otherwise responsible for any decision made or any
action taken or not taken by you as a result of the information presented.
BE A WELL-INFORMED
CONSUMER. READ THE FOLLOWING MATERIALS ABOUT
THROMBOCYTOPENIA, CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA,AND EUPHORBIA HIRTA.
refers to the presence of abnormally low levels of platelets in the circulating
blood.” It is usually defined as less
than 150,000 platelets per cubic millimeter of blood (150 x
10/uL). The normal platelet count
range is 150–400 x 10/uL.
affects a patient’s quality of life and can significantly increase the cost of
© 2013-2016 Drewmarc Corporation